For women on GLP-1 therapy who are losing weight at a meaningful pace, bone health is worth monitoring, particularly in perimenopausal and postmenopausal women where estrogen-related bone protection is already diminishing
Preventive measures To mitigate these impacts, a multi-stakeholder approach is essential: Stricter Prescription Oversight: The Dubai Health Authority (DHA) and insurance providers must collaborate to define clear prescribing and coverage guidelines
Strengths, limitations and future directions This narrative review has several strengths, including the timely synthesis of emerging evidence on the potential role of GLP-1 receptor agonists in the management of IIH
Anyone with a known allergy to glutathione or its ingredients
These medications mimic the glucagon-like peptide-1 (GLP-1) hormone, which naturally helps control appetite, slow digestion, and regulate insulin response